Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Ichor Holdings
ICHR
$582M
| $3.31M | ﹤0.01% |
61,500
-900
| -1% | -$48.4K |
|
1777
The RealReal
REAL
$1.12B
| $3.31M | ﹤0.01% |
167,300
+116,700
| +231% | +$2.31M |
|
1778
Ameresco
AMRC
$1.43B
| $3.31M | ﹤0.01% |
52,700
+4,900
| +10% | +$307K |
|
1779
Laureate Education
LAUR
$4.31B
| $3.29M | ﹤0.01% |
226,500
-5,100
| -2% | -$74K |
|
1780
Revolution Medicines
RVMD
$8.59B
| $3.28M | ﹤0.01% |
103,400
+57,900
| +127% | +$1.84M |
|
|
HIBB
1781
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $3.28M | ﹤0.01% |
36,600
-1,200
| -3% | -$108K |
|
1782
US Physical Therapy
USPH
$1.23B
| $3.28M | ﹤0.01% |
28,300
-1,100
| -4% | -$127K |
|
1783
Hudbay
HBM
$5.32B
| $3.28M | ﹤0.01% |
491,300
-47,100
| -9% | -$314K |
|
1784
Encore Capital Group
ECPG
$1.02B
| $3.28M | ﹤0.01% |
69,100
+4,600
| +7% | +$218K |
|
1785
Sphere Entertainment
SPHR
$2.03B
| $3.27M | ﹤0.01% |
38,933
+3,100
| +9% | +$260K |
|
1786
ArcBest
ARCB
$1.63B
| $3.26M | ﹤0.01% |
56,000
-2,100
| -4% | -$122K |
|
1787
RadNet
RDNT
$5.58B
| $3.26M | ﹤0.01% |
96,700
-3,600
| -4% | -$121K |
|
1788
Tennant Co
TNC
$1.51B
| $3.26M | ﹤0.01% |
40,800
+700
| +2% | +$55.9K |
|
|
DCPH
1789
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.26M | ﹤0.01% |
88,900
+4,300
| +5% | +$157K |
|
1790
Buckle
BKE
$3.08B
| $3.25M | ﹤0.01% |
65,300
-2,500
| -4% | -$124K |
|
1791
PBF Energy
PBF
$3.21B
| $3.24M | ﹤0.01% |
211,800
-21,500
| -9% | -$329K |
|
1792
Porch Group
PRCH
$1.81B
| $3.24M | ﹤0.01% |
+167,500
| New | +$3.24M |
|
1793
Sangamo Therapeutics
SGMO
$152M
| $3.21M | ﹤0.01% |
268,360
-6,300
| -2% | -$75.4K |
|
1794
Green Plains
GPRE
$635M
| $3.21M | ﹤0.01% |
95,400
-3,200
| -3% | -$108K |
|
1795
Castle Biosciences
CSTL
$630M
| $3.21M | ﹤0.01% |
43,700
+2,300
| +6% | +$169K |
|
1796
TTM Technologies
TTMI
$4.84B
| $3.2M | ﹤0.01% |
223,600
-8,100
| -3% | -$116K |
|
1797
Brookdale Senior Living
BKD
$1.76B
| $3.2M | ﹤0.01% |
404,439
+6,300
| +2% | +$49.8K |
|
|
GOGL
1798
DELISTED
Golden Ocean Group
GOGL
| $3.19M | ﹤0.01% |
287,924
+77,002
| +37% | +$854K |
|
1799
Primoris Services
PRIM
$6.6B
| $3.19M | ﹤0.01% |
108,300
+2,900
| +3% | +$85.3K |
|
1800
St. Joe Company
JOE
$3.01B
| $3.19M | ﹤0.01% |
71,400
-2,600
| -4% | -$116K |
|